Search clinical trials for: Fluzone®

Total 20062 results

Sanofi Pasteur, a Sanofi Company

Completed

Anti-Hep B Antibodies at Age 9 to 10 Years After Hep B Vaccine at Birth and DTaP-IPV-Hep B-PRP-T Hexavalent Vaccine.

Hepatitis B

Thailand
Azidus Brasil
Cellavita Pesquisa Científica Ltda

Not yet recruiting

Efficacy and Safety of NestaCell® in Huntington's Disease (STAR)

Huntington Disease
UCB Pharma

Completed

An Open-label follow-on Trial to Assess the Long-term Safety and Efficacy of Oral SPM 927 in Subjects With Diabetic Neuropathy

Painful Diabetic Neuropathy
Orient Pharma Co., Ltd.
Durect

Completed

Evaluate Long-term Safety and Efficacy of ORADUR®-Methylphenidate in Children and Adolescents With ADHD

Attention Deficit Hyperactivity Disorder

Taiwan
Fresenius Kabi SwissBioSim GmbH

Completed

MSB11022 in Healthy Subjects

Healthy Subjects
Yuyu Pharma, Inc.

Completed

Pharmacokinetics of Maxmarvil® in Healthy Postmenopausal Women (YY_PK_2011)

Osteoporosis

Korea, Republic of
UCB Pharma

Completed

An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Advanced-Stage Parkinson's Disease

Advanced Stage Parkinson's Disease

France, Italy, Poland, United Kingdom, Spain, Germany, South Africa, New Zealand, Czech Republic, Hungary, Australia, Austria, Israel, Sweden, Norway, Croatia, Finland
ONIRIS

Completed

Mandibular Advancement Devices Tali® in Patients With Syndrome of Obstructive Sleep Apnea and Hypopneas

Syndrome of Obstructive Sleep Apnea and Hypopneas

France
Enzymotec

Completed

Vayarin® Medical Food Study for Adults With Attention Deficit Hyperactivity Disorder (ADHD)

Attention Deficit Hyperactivity Disorder (ADHD)

United States
Veloxis Pharmaceuticals

Approved for marketing

Expanded Access Study for Renal Transplant Patients With Envarsus XR ™

Renal Failure
Andreas Benesic, MD
MetaHeps GmbH

Unknown

Cells of Monocytic Origin as Surrogate Markers for Individual Drug Effects and Hepatotoxicity

Adverse Reaction to Drug | Drug-induced Disorder of Liver

Hong Kong, Australia, Germany, Japan, Korea, Republic of
Sanofi Pasteur, a Sanofi Company

Completed

Persistence of Bactericidal Antibodies in Adolescents and Adults Who Had Received a Single Dose of Menactra® Vaccine

Meningitis | Meningococcal Infections

United States
University Health Network, Toronto

Completed

High Dose vs. Standard Influenza Vaccine in Adult SOT

Influenza | Immunosuppression

Canada
Seqirus

Completed

A Study to Determine the Immunogenicity and Safety Profile of CSL Limited's Influenza Virus Vaccine Compared to a US Licensed Comparator Influenza Virus Vaccine in a Pediatric Population

Influenza

United States
Bayer

Completed

Low-dose Nifedipine-Valsartan Combination Compared to Up-titrated Valsartan Monotherapy in Essential Hypertension

Hypertension

China, Korea, Republic of
Astellas Scientific & Medical Affairs, Inc.

Completed

A Prospective, Observational, Multicenter Study of Patients Following Initiation of a New Course of Treatment for Overactive Bladder (OAB) (PERSPECTIVE)

Urologic Diseases | Overactive Bladder | Urinary Bladder Diseases | Urinary Bladder Overactive

United States, Canada
Liquidia Technologies, Inc.
Children's Hospital Medical Center, Cincinnati; Accelovance

Completed

A Study Evaluating the Safety and Tolerability of a Seasonal Influenza Vaccine Containing LIQ001 (LIfT)

Influenza

United States
Novartis Pharmaceuticals

Terminated

LFF269 Compared to Placebo After Treatment in Subjects With Essential Hypertension

Hypertension

United States
Gedeon Richter Plc.

Completed

Comparative Efficacy and Safety Study of RGB-14-P and Prolia® in Women With Postmenopausal Osteoporosis

Postmenopausal Osteoporosis

Poland, United States, Spain, Hungary, Italy, Czechia, Bulgaria, Ukraine
UCB Pharma GmbH

Completed

Observational Study With Neupro® to Evaluate the Patient´s Perception of Pain Associated With Parkinson´s Disease (NEUPAD)

Idiopathic Parkinson's Disease

Germany, Austria
UCB Pharma

Completed

A Trial to Investigate Safety and Efficacy of SPM927 in Painful Diabetic Neuropathy

Painful Diabetic Neuropathy
UCB Pharma

Completed

An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Early-Stage Parkinson's Disease

Early Stage Parkinson's Disease

Poland, United Kingdom, Germany, Spain, Switzerland, Belgium, South Africa, New Zealand, Czech Republic, Austria, Hungary, Australia, Italy, Israel, Sweden, Norway, Croatia, Netherlands, Finland, France
UCB Pharma

Completed

An Open-Label Extension Trial to Assess the Safety and Tolerability of Long Term Treatment of Rotigotine in Subjects With Idiopathic Parkinson's Disease

Idiopathic Parkinson's Disease

United States, Germany, Spain, Austria, Israel, Italy, South Africa, United Kingdom
UCB Pharma

Completed

Belgian Drug-utilization Study to Evaluate the Use of VIMPAT® as Adjunctive Treatment of Partial Onset Seizures in Subjects Aged 16 and Older

Seizures

Belgium
University Hospital, Basel, Switzerland

Recruiting

Hyperinsulinemia in Prediabetes Mediated by Interleukin-1β (Hyper-PreDIL)

PreDiabetes | Hyperinsulinemia

Switzerland
Geistlich Pharma AG
TigerMed

Recruiting

Chondro-Gide® Bilayer Collagen Membrane in Knee Cartilage Defect Repair

Cartilage Defects

China
UCB Pharma

Completed

A Multi-Centre, Randomized, Double-Blind, Placebo Controlled Pilot Trial to Assess the Efficacy, Safety, and Tolerability of SPM 927 in Subjects With Postherpetic Neuralgia (PHN).

Postherpetic Neuralgia
Orient Pharma Co., Ltd.
Durect

Completed

Evaluate Safety and Efficacy of ORADUR®-Methylphenidate in Children and Adolescents With ADHD

Attention Deficit Hyperactivity Disorder

Taiwan
UCB Pharma

Completed

Study in Healthy Volunteers to Prove That Two Rotigotine Patches From Different Manufacturing Sites Deliver Equivalent Drug Amount to the Body

Healthy Volunteers

Germany
UCB Pharma

Completed

Named Patient Program With Rotigotine Transdermal System

Conditions for Which There is a Documented Medical Necessity to Receive Treatment With Rotigotine

United States
UCB Pharma

Completed

Long-term Open-label Trial in Idiopathic Restless Legs Syndrome (RLS)

Restless Legs Syndrome

Germany, Spain, Austria
University of Zurich

Withdrawn

Clevidipine (Cleviprex®) Compared With Urapidil (Ebrantil®) (Clevidipine)

Nontraumatic Intracerebral Hemorrhage, Multiple Localized

Switzerland
ANM Adaptive Neuromodulation GmbH
CERES GmbH

Completed

Acoustic Coordinated Reset (CR®) Neuromodulation for the Treatment of Chronic Tonal Tinnitus ("RESET Real Life") (RRL)

Tinnitus

Germany
Klinik für Kardiologie, Pneumologie und Angiologie

Recruiting

MitraClip® Registry

Mitral Regurgitation

Germany
Fundación Investigación E Innovación Biomédica...
Universidad Autonoma de Madrid; IMDEA Food

Completed

Rosmalip® for Cancer Infections Prevention (OnCOVInf)

Infections | Cancer | Covid19

Spain
Tanta University

Completed

Beta-Tricalcium Phosphate and Concentrated Growth Factors in Treatment of Intra-bony Defect Randomized Clinical Trial (RCT)

Chronic Periodontitis | Intrabony Periodontal Defect | Concentrated Growth Factors

Egypt
Brainfarma Industria Química e Farmacêutica S/A
Techtrials Pesquisa e Tecnologia Ltda; Pharmagenix

Unknown

Study Comparing Coristina® D to Resfenol® in the Symptomatic Treatment of Common Cold

Cold
Ethicon, Inc.

Recruiting

GYNEMESH PS Mesh Post Marketing Clinical Follow-Up Study

Pelvic Organ Prolapse

United States, Germany
Bristol-Myers Squibb

Active, not recruiting

A Study to Compare the Response to Treatment With Abatacept vs Adalimumab, on Background Methotrexate, in Adults With Early, Seropositive, and Shared Epitope-positive Rheumatoid Arthritis and an Inadequate Response to Methotrexate

Rheumatoid Arthritis

Italy, United States, Germany, Argentina, Australia, Czechia, France, Japan, Mexico, Poland, Spain, Switzerland, Taiwan, United Kingdom
University Hospital, Basel, Switzerland

Completed

Neoveil® Versus TachoSil® for the Treatment of Pulmonary Air Leaks Following Lung Operation

Prolonged Air Leak | Postoperative Air Leak

Switzerland
FeetMe

Completed

Validation Study : FeetMe® Monitor Insoles for the Evaluation of Gait Speed

Healthy

France
Sanofi Pasteur, a Sanofi Company

Completed

Study of Reduced Dose of Menomune® in Children Who Previously Received Meningococcal Diphtheria Toxoid Conjugate Vaccine

Meningitis | Neisseria Meningitidis | Meningococcemia

United States
Sanofi Pasteur, a Sanofi Company

Completed

Study of DTap-IPV Compared to DAPTACEL® and IPOL® as the 5th Dose in Children 4 to 6 Years of Age

Measles | Pertussis | Tetanus | Diphtheria | Polio

United States, Puerto Rico
Alcon Research

Completed

Visual Function After Bilateral Implantation of AcrySof® Toric

Visual Function

United States
Alexion Pharmaceuticals

Terminated

Safety & Efficacy of Eculizumab to Prevent AMR in Living Donor Kidney Transplant Recipients Requiring Desensitization

Antibody Mediated Rejection

United States, Germany, Italy, France, United Kingdom, Spain, Sweden, Australia, Netherlands, Norway
Shandong University
Qilu Hospital of Shandong University

Recruiting

Evaluation of AHCC® for the Clearance of High Risk-HPV Infections in Chinese Female

High Risk Human Papillomavirus Infection | Low Grade Squamous Intraepithelial Lesion

China
National Taiwan University Hospital

Unknown

Long-term Efficacy of Carglumic Acid in Organic Acidemia.

Propionic Acidemia (PA) , Methylmalonic Acidemia (MMA)

Taiwan
Sanofi Pasteur, a Sanofi Company

Completed

Immunogenicity of Adacel® and BOOSTRIX® Vaccines in Adolescents

Pertussis | Whooping Cough | Tetanus | Diphtheria

United States
Sanofi Pasteur, a Sanofi Company

Completed

Study of Sanofi Pasteur and Lanzhou Institute's Meningococcal (Group A and C) Polysaccharide Vaccine in Children

Meningitis | Meningococcal Disease

China
Alza Corporation, DE, USA

Completed

A Study Comparing the Efficacy and Safety of OROS® Oxybutynin to That of Ditropan® (Immediate-release Oxybutynin) for the Treatment of Patients With Urge or Mixed Urinary Incontinence.

Urge Incontinence

Search clinical trials for: Fluzone®

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Madagascar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations